(Q35749406)

10 August 2017

1 reference

title

Focus on head and neck cancer (English)

1 reference

10 August 2017

head and neck carcinoma

1 reference

Vassiliki Papadimitrakopoulou

inferred from title

author

series ordinal

3

object named as

Vassiliki A Papadimitrakopoulou

1 reference

10 August 2017

Li Mao

1

1 reference

PubMed ID

15093538

10 August 2017

Waun K Hong

series ordinal

2

1 reference

10 August 2017

1 April 2004

1 reference

10 August 2017

1 reference

10 August 2017

5

1 reference

10 August 2017

311-316

1 reference

10 August 2017

4

1 reference

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Alternative and aberrant splicing of MDM2 mRNA in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Risk factors in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

1 reference

7 January 2021

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Patterns of gene promoter methylation in squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Gene silencing in cancer in association with promoter hypermethylation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Recent advances in chemoprevention of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

13-cis-retinoic acid in the treatment of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Multiple oral squamous epithelial lesions: are they genetically related?

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Oral cancer and precancerous lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Biochemoprevention for dysplastic lesions of the upper aerodigestive tract

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

DeltaNp63 induces beta-catenin nuclear accumulation and signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

The role of epidermal growth factor receptor in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

DNA content as a prognostic marker in patients with oral leukoplakia.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

The influence of resection and aneuploidy on mortality in oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

1 reference

7 January 2021

Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900090-X

7 January 2021

10.1016/S1535-6108(04)00090-X

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15093538